financetom
Business
financetom
/
Business
/
Vertical farming startup Plenty to expand via $680 million JV with UAE's Mawarid
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vertical farming startup Plenty to expand via $680 million JV with UAE's Mawarid
Jul 19, 2024 1:29 PM

(This July 18 story has been corrected to clarify that 4.5 million pounds is an annual figure in paragraph 3 and removes reference to 'stacked layers' in paragraph 5)

By Krystal Hu

(Reuters) - U.S. vertical farming startup Plenty is forming a joint venture with Mawarid, a subsidiary of Alpha Dhabi Holding, in a $680 million deal to develop a network of indoor farms in the Middle East, the companies told Reuters.

The joint venture plans to build five farms in the region over the next five years. An initial combined investment of about $130 million by the companies will fund the construction of an indoor farm in Abu Dhabi that is expected to break ground early next year and could be up and running by 2026.

The farm aims to produce over 4.5 million pounds of premium strawberries annually for local consumption and export within Gulf Cooperation Council member countries.

Part of the financing also comes from debt provided by a local bank in the region, highlighting an unusual source of capital for the capital intensive indoor farming industry that has raised billions from venture capital investors.

Vertical farms in controlled indoor environments are promoted as a sustainable way to grow fruits and vegetables closer to the point of consumption while using less water.

The high costs associated with building new facilities have been a significant barrier to scaling production and funding for indoor farming has declined to just a fifth of its peak in 2021, according to PitchBook.

"We are targeting returns north of 20%, which is significantly higher than traditional agriculture. In that context, we think there's a lot of capital for the space," said Arama Kukutai, CEO of San Francisco-based Plenty.

Plenty said its United Arab Emirates farm's strawberry production has been pre-sold to Driscoll's, which dominates the market for berries in the region.

The partnership comes as the indoor farming sector is seeking new financial avenues to sustain growth. In early 2022, Plenty raised $400 million at a valuation of $1.43 billion, according to PitchBook. To date, Plenty has raised over $940 million from investors including Softbank and Walmart.

"We've been looking to bring food security into the UAE. We want to offer a solution which was able to deal with the issue of scarce land and scarce water, and could pivot to different crops if necessary," Mawarid CEO Kashif Shamsi said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Germany's Commerzbank has a bumpy history with big M&A
Germany's Commerzbank has a bumpy history with big M&A
Sep 21, 2024
FRANKFURT (Reuters) -Commerzbank is poised to put CFO Bettina Orlopp in charge of talks with UniCredit when the German bank's supervisory board meets next week, two people with knowledge of the matter said, as the Italian rival considers a takeover. Commerzbank has, like some other banks, had a rocky history with big mergers and acquisitions over the years. These are...
Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant
Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant
Sep 21, 2024
(Reuters) -Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's breakthrough device designation. The FDA's breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening conditions. It is aimed at speeding up development and review of devices currently under development. The experimental...
Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children
Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children
Sep 21, 2024
On Wednesday, the FDA granted 510(k) clearance to Vivos Therapeutics, Inc.’s flagship oral medical device, which is used to treat moderate to severe obstructive sleep apnea (OSA) and snoring in children. Recent published studies report up to 10.1 million U.S. children (ages 6-17) are estimated to suffer from pediatric OSA. Vivos’ DNA appliance is non-invasive, safe, comfortable, affordable, and highly effective....
TIMELINE-Germany's Commerzbank has a bumpy history with big M&A
TIMELINE-Germany's Commerzbank has a bumpy history with big M&A
Sep 21, 2024
(Updates timeline originally published on Sept. 11 with latest developments) By Tom Sims FRANKFURT, Sept 18 (Reuters) - Commerzbank is poised to put CFO Bettina Orlopp in charge of talks with UniCredit when the German bank's supervisory board meets next week, two people with knowledge of the matter said, as the Italian rival considers a takeover. Commerzbank has, like some...
Copyright 2023-2026 - www.financetom.com All Rights Reserved